US Stock MarketDetailed Quotes

BCRX BioCryst Pharmaceuticals

Watchlist
  • 4.160
  • -0.050-1.19%
Close Apr 25 16:00 ET
  • 4.170
  • +0.010+0.24%
Post 17:11 ET
857.58MMarket Cap-3525P/E (TTM)

BioCryst Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
22.37%331.41M
17.42%93.4M
14.39%86.74M
25.88%82.49M
37.77%68.78M
72.31%270.83M
68.68%79.55M
84.97%75.83M
31.17%65.53M
161.94%49.92M
Operating revenue
22.37%331.41M
17.42%93.4M
14.39%86.74M
25.88%82.49M
37.64%68.41M
72.31%270.83M
68.68%79.55M
84.97%75.83M
31.17%65.53M
160.79%49.7M
Cost of revenue
-29.31%4.66M
-34.42%1.64M
-68.56%1.14M
284.62%950K
294.12%938K
-9.22%6.59M
495.70%2.5M
487.48%3.61M
-27.99%247K
-95.98%238K
Gross profit
23.66%326.75M
19.10%91.76M
18.54%85.61M
24.90%81.54M
36.54%67.84M
76.27%264.23M
64.85%77.05M
78.84%72.21M
31.58%65.29M
278.24%49.69M
Operating expense
4.31%430.46M
8.98%134.43M
8.78%97.53M
2.24%102.24M
-3.40%96.26M
25.96%412.67M
24.71%123.36M
5.53%89.66M
26.27%100.01M
54.45%99.64M
Selling and administrative expenses
34.21%213.89M
28.37%64.38M
37.19%50.65M
34.14%51M
39.63%47.87M
34.13%159.37M
41.73%50.15M
5.51%36.92M
44.41%38.02M
55.02%34.28M
Research and development costs
-14.50%216.57M
-4.31%70.05M
-11.11%46.88M
-17.33%51.25M
-25.97%48.39M
21.31%253.3M
15.23%73.21M
5.54%52.74M
17.24%61.99M
54.02%65.36M
Operating profit
30.13%-103.71M
7.86%-42.67M
31.67%-11.92M
40.37%-20.7M
43.12%-28.42M
16.48%-148.44M
11.24%-46.31M
60.87%-17.45M
-17.38%-34.72M
2.76%-49.96M
Net non-operating interest income expense
1.60%-92.46M
15.31%-20.12M
-0.63%-23.16M
-7.48%-25.17M
-0.99%-24.02M
-58.64%-93.97M
-26.58%-23.75M
-63.16%-23.02M
-73.66%-23.41M
-84.68%-23.78M
Non-operating interest income
207.72%15.78M
65.13%4.47M
137.73%4.18M
515.76%3.75M
6,155.56%3.38M
8,169.35%5.13M
19,214.29%2.7M
19,455.56%1.76M
4,584.62%609K
107.69%54K
Non-operating interest expense
9.23%108.24M
-7.09%24.58M
10.37%27.35M
20.37%28.92M
14.93%27.4M
67.12%99.09M
40.88%26.46M
75.52%24.78M
78.01%24.02M
84.73%23.84M
Other net income (expense)
-1,415.78%-30.06M
73.29%-374K
-36.99%-737K
-21,856.06%-28.72M
-29.38%-229K
-103.60%-1.98M
-102.53%-1.4M
-384.68%-538K
198.51%132K
-510.34%-177K
Gain on sale of security
47.60%-1.04M
73.29%-374K
-36.99%-737K
128.03%301K
-29.38%-229K
-185.32%-1.98M
-232.54%-1.4M
-384.68%-538K
198.51%132K
-510.34%-177K
Special income (charges)
---29.02M
--0
--0
---29.02M
----
--0
--0
--0
--0
----
-Less:Other special charges
--29.02M
--0
----
--29.02M
----
----
----
----
----
----
Income before tax
7.43%-226.23M
11.62%-63.16M
12.63%-35.82M
-28.59%-74.59M
28.76%-52.66M
-34.42%-244.38M
-360.29%-71.47M
30.28%-41M
-34.27%-58M
-14.99%-73.92M
Income tax
-88.66%310K
-1,982.89%-1.43M
-78.32%330K
-13.55%740K
140.50%671K
21.30%2.73M
-96.63%76K
1.52M
856K
279K
Net income
8.33%-226.54M
13.71%-61.73M
14.98%-36.15M
-27.98%-75.33M
28.12%-53.33M
-34.26%-247.12M
-302.39%-71.54M
27.69%-42.52M
-36.25%-58.86M
-15.42%-74.2M
Net income continuous Operations
8.33%-226.54M
13.71%-61.73M
14.98%-36.15M
-27.98%-75.33M
28.12%-53.33M
-34.26%-247.12M
-302.39%-71.54M
27.69%-42.52M
-36.25%-58.86M
-15.42%-74.2M
Minority interest income
Net income attributable to the parent company
8.33%-226.54M
13.71%-61.73M
14.98%-36.15M
-27.98%-75.33M
28.12%-53.33M
-34.26%-247.12M
-302.39%-71.54M
27.69%-42.52M
-36.25%-58.86M
-15.42%-74.2M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
8.33%-226.54M
13.71%-61.73M
14.98%-36.15M
-27.98%-75.33M
28.12%-53.33M
-34.26%-247.12M
-302.39%-71.54M
27.69%-42.52M
-36.25%-58.86M
-15.42%-74.2M
Basic earnings per share
11.28%-1.18
18.42%-0.31
17.39%-0.19
-25.00%-0.4
30.00%-0.28
-29.13%-1.33
-280.00%-0.38
30.30%-0.23
-33.33%-0.32
-11.11%-0.4
Diluted earnings per share
11.28%-1.18
18.42%-0.31
17.39%-0.19
-25.00%-0.4
30.00%-0.28
-29.13%-1.33
-280.00%-0.38
30.30%-0.23
-33.33%-0.32
-11.11%-0.4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 22.37%331.41M17.42%93.4M14.39%86.74M25.88%82.49M37.77%68.78M72.31%270.83M68.68%79.55M84.97%75.83M31.17%65.53M161.94%49.92M
Operating revenue 22.37%331.41M17.42%93.4M14.39%86.74M25.88%82.49M37.64%68.41M72.31%270.83M68.68%79.55M84.97%75.83M31.17%65.53M160.79%49.7M
Cost of revenue -29.31%4.66M-34.42%1.64M-68.56%1.14M284.62%950K294.12%938K-9.22%6.59M495.70%2.5M487.48%3.61M-27.99%247K-95.98%238K
Gross profit 23.66%326.75M19.10%91.76M18.54%85.61M24.90%81.54M36.54%67.84M76.27%264.23M64.85%77.05M78.84%72.21M31.58%65.29M278.24%49.69M
Operating expense 4.31%430.46M8.98%134.43M8.78%97.53M2.24%102.24M-3.40%96.26M25.96%412.67M24.71%123.36M5.53%89.66M26.27%100.01M54.45%99.64M
Selling and administrative expenses 34.21%213.89M28.37%64.38M37.19%50.65M34.14%51M39.63%47.87M34.13%159.37M41.73%50.15M5.51%36.92M44.41%38.02M55.02%34.28M
Research and development costs -14.50%216.57M-4.31%70.05M-11.11%46.88M-17.33%51.25M-25.97%48.39M21.31%253.3M15.23%73.21M5.54%52.74M17.24%61.99M54.02%65.36M
Operating profit 30.13%-103.71M7.86%-42.67M31.67%-11.92M40.37%-20.7M43.12%-28.42M16.48%-148.44M11.24%-46.31M60.87%-17.45M-17.38%-34.72M2.76%-49.96M
Net non-operating interest income expense 1.60%-92.46M15.31%-20.12M-0.63%-23.16M-7.48%-25.17M-0.99%-24.02M-58.64%-93.97M-26.58%-23.75M-63.16%-23.02M-73.66%-23.41M-84.68%-23.78M
Non-operating interest income 207.72%15.78M65.13%4.47M137.73%4.18M515.76%3.75M6,155.56%3.38M8,169.35%5.13M19,214.29%2.7M19,455.56%1.76M4,584.62%609K107.69%54K
Non-operating interest expense 9.23%108.24M-7.09%24.58M10.37%27.35M20.37%28.92M14.93%27.4M67.12%99.09M40.88%26.46M75.52%24.78M78.01%24.02M84.73%23.84M
Other net income (expense) -1,415.78%-30.06M73.29%-374K-36.99%-737K-21,856.06%-28.72M-29.38%-229K-103.60%-1.98M-102.53%-1.4M-384.68%-538K198.51%132K-510.34%-177K
Gain on sale of security 47.60%-1.04M73.29%-374K-36.99%-737K128.03%301K-29.38%-229K-185.32%-1.98M-232.54%-1.4M-384.68%-538K198.51%132K-510.34%-177K
Special income (charges) ---29.02M--0--0---29.02M------0--0--0--0----
-Less:Other special charges --29.02M--0------29.02M------------------------
Income before tax 7.43%-226.23M11.62%-63.16M12.63%-35.82M-28.59%-74.59M28.76%-52.66M-34.42%-244.38M-360.29%-71.47M30.28%-41M-34.27%-58M-14.99%-73.92M
Income tax -88.66%310K-1,982.89%-1.43M-78.32%330K-13.55%740K140.50%671K21.30%2.73M-96.63%76K1.52M856K279K
Net income 8.33%-226.54M13.71%-61.73M14.98%-36.15M-27.98%-75.33M28.12%-53.33M-34.26%-247.12M-302.39%-71.54M27.69%-42.52M-36.25%-58.86M-15.42%-74.2M
Net income continuous Operations 8.33%-226.54M13.71%-61.73M14.98%-36.15M-27.98%-75.33M28.12%-53.33M-34.26%-247.12M-302.39%-71.54M27.69%-42.52M-36.25%-58.86M-15.42%-74.2M
Minority interest income
Net income attributable to the parent company 8.33%-226.54M13.71%-61.73M14.98%-36.15M-27.98%-75.33M28.12%-53.33M-34.26%-247.12M-302.39%-71.54M27.69%-42.52M-36.25%-58.86M-15.42%-74.2M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 8.33%-226.54M13.71%-61.73M14.98%-36.15M-27.98%-75.33M28.12%-53.33M-34.26%-247.12M-302.39%-71.54M27.69%-42.52M-36.25%-58.86M-15.42%-74.2M
Basic earnings per share 11.28%-1.1818.42%-0.3117.39%-0.19-25.00%-0.430.00%-0.28-29.13%-1.33-280.00%-0.3830.30%-0.23-33.33%-0.32-11.11%-0.4
Diluted earnings per share 11.28%-1.1818.42%-0.3117.39%-0.19-25.00%-0.430.00%-0.28-29.13%-1.33-280.00%-0.3830.30%-0.23-33.33%-0.32-11.11%-0.4
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg